Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)

被引:65
作者
Tolleson, TR
Newby, LK
Harrington, RA
Bhapkar, MV
Verheught, FWA
Berger, PB
Moliterno, DJ
White, HD
Ohman, EM
Van de Werf, F
Topol, EJ
Califf, RM
机构
[1] Duke Clin Res Inst, Durham, NC 27715 USA
[2] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[3] Mayo Clin, Rochester, MN USA
[4] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[5] Green Lane Hosp, Auckland 3, New Zealand
[6] Univ N Carolina, Chapel Hill, NC USA
[7] Univ Ziekenhuizen, Louvain, Belgium
关键词
D O I
10.1016/s0002-9149(03)00641-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied stent thrombosis in 4,607 patients with acute coronary syndromes who received a coronary stent as part of routine care during 2 trials of aspirin versus sibrafiban for secondary prevention. In these patients, stent thrombosis occurred more often than in previous patients who underwent elective percutaneous coronary intervention. These patients and their outcomes may be more representative of patients with typical acute coronary syndromes undergoing stenting in clinical practice. (C) 2003 by Excerpta Medica, Inc.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 12 条
[1]   Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting - The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study [J].
Bertrand, ME ;
Legrand, V ;
Boland, J ;
Fleck, E ;
Bonnier, J ;
Emmanuelson, H ;
Vrolix, M ;
Missault, L ;
Chierchia, S ;
Casaccia, M ;
Niccoli, L ;
Oto, A ;
White, C ;
Webb-Peploe, M ;
Van Belle, E ;
McFadden, EP .
CIRCULATION, 1998, 98 (16) :1597-1603
[2]  
Cutlip DE, 2001, CIRCULATION, V103, P1967
[3]   A clinical trial comparing three antithrombotic drug regimens after coronary-artery stenting [J].
Leon, MB ;
Baim, DS ;
Popma, JJ ;
Gordon, PC ;
Cutlip, DE ;
Ho, KKL ;
Giambartolome, A ;
Diver, DJ ;
Lasorda, DM ;
Williams, DO ;
Pocock, SJ ;
Kuntz, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23) :1665-1671
[4]   Subacute stent thrombosis: Evolving issues and current concepts [J].
Mak, KH ;
Belli, G ;
Ellis, SG ;
Moliterno, DJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (02) :494-503
[5]  
Newby K, 2001, CIRCULATION, V103, P1727
[7]   Frequency and correlates of coronary stent thrombosis in the modern era - Analysis of a single center registry [J].
Orford, JL ;
Lennon, R ;
Melby, S ;
Fasseas, P ;
Bell, MR ;
Rihal, CS ;
Holmes, DR ;
Berger, PB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (09) :1567-1572
[8]   A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents [J].
Schomig, A ;
Neumann, FJ ;
Kastrati, A ;
Schuhlen, H ;
Blasini, R ;
Hadamitzky, M ;
Walter, H ;
ZitzmannRoth, EM ;
Richardt, G ;
Alt, E ;
Schmitt, C ;
Ulm, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (17) :1084-1089
[9]   Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement - Analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial [J].
Schuhlen, H ;
Hadamitzky, M ;
Walter, H ;
Ulm, K ;
Schomig, A .
CIRCULATION, 1997, 95 (08) :2015-2021
[10]   Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. [J].
Stone, GW ;
Grines, CL ;
Cox, DA ;
Garcia, E ;
Tcheng, JE ;
Griffin, JJ ;
Guagliumi, G ;
Stuckey, T ;
Turco, M ;
Carroll, JD ;
Rutherford, BD ;
Lansky, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) :957-966